NCT01652495View on ClinicalTrials.gov

Evaluation of Efficacy and Hypothalamus-pituitary-adrenal Axis Suppression Due to Corticosteroids Intrabursal Injection

PHASE4CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
TendinopathyAdrenal Insufficiency
Interventions
DRUG

methylprednisolone acetate

Single intrabursal ultrasound guided injection of 40 mg (1 ml) of methylprednisolone acetate

DRUG

Triamcinolone Acetonide

Single intrabursal ultrasound guided injection of 40 mg (1 ml) of triamcinolone acetonide

Trial Locations (1)

40136

Rizzoli Orthopaedic Institute, Bologna

All Listed Sponsors
collaborator

Azienda Ospedaliera San Giovanni Battista

OTHER

lead

Istituto Ortopedico Rizzoli

OTHER

NCT01652495 - Evaluation of Efficacy and Hypothalamus-pituitary-adrenal Axis Suppression Due to Corticosteroids Intrabursal Injection | Biotech Hunter | Biotech Hunter